Loading clinical trials...
Loading clinical trials...
The aim of this study is to identify a dysplasia- and CCA-specific NGS panel to increase the diagnostic sensitivity of histological and/or cytological examination of biliary tract stenosis.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT00242723 · Malignant Pleural Mesotheliomas NOS, Esophageal Cancers NOS, and more
NCT07048249 · Ewings Sarcoma, Chemotherapy Induced Thrombocytopenia
NCT07466420 · Fibrotic Interstitial Lungs Diseases, Idiopathic Pulmonary Fibrosis (IPF), and more
NCT07464444 · Auscultation of Heart and Lungs
NCT03546374 · Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions